Clinical trial
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast…
NCT00427427 · Jonsson Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00427427 |
|---|---|
| Title | Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer |
| Official title | A Phase II Trial of Delayed Adjuvant Herceptin® in Patients With HER-2 Positive Breast Cancer |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Trastuzumab |
| Enrollment | 75 |
| Start date | Jan 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 29, 2007 |
| Last update posted | Aug 1, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: